减瘤手术及腹腔热灌注化疗在结直肠癌腹膜转移治疗中的作用
Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastases.
作者信息
Shah Rupen, Gangi Alexandra
机构信息
Division of Surgical Oncology, Henry Ford Cancer Institute/Henry Ford Health, Detroit, Michigan.
Division of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, California.
出版信息
Clin Colon Rectal Surg. 2023 Mar 13;37(2):90-95. doi: 10.1055/s-0042-1758759. eCollection 2024 Mar.
Abstract
Peritoneal metastases from colon cancer are a particularly challenging disease process given the limited response to systemic chemotherapy. In patients with isolated peritoneal metastases, cytoreductive surgery with hyperthermic intraperitoneal chemotherapy offers a potential treatment option to these patients with limited peritoneal metastases as long as a complete cytoreduction is achieved. Decision about a patient's candidacy for this treatment modality should be undertaken by a multidisciplinary group at expert centers.
摘要
鉴于结肠癌腹膜转移对全身化疗的反应有限，它是一个特别具有挑战性的疾病过程。对于孤立性腹膜转移患者，只要能实现完全细胞减灭，细胞减灭术联合腹腔内热化疗为这些腹膜转移有限的患者提供了一种潜在的治疗选择。关于患者是否适合这种治疗方式的决定应由专家中心的多学科团队做出。
相似文献
1
Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastases.
Clin Colon Rectal Surg. 2023 Mar 13;37(2):90-95. doi: 10.1055/s-0042-1758759. eCollection 2024 Mar.
2
Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
Dis Colon Rectum. 2019 Oct;62(10):1195-1203. doi: 10.1097/DCR.0000000000001456.
3
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes.
Langenbecks Arch Surg. 2021 Dec;406(8):2797-2805. doi: 10.1007/s00423-021-02353-z. Epub 2021 Oct 18.
4
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol. 2021 Feb;22(2):256-266. doi: 10.1016/S1470-2045(20)30599-4. Epub 2021 Jan 18.
5
[Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 May 25;26(5):434-441. doi: 10.3760/cma.j.cn441530-20230309-00071.
6
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
JMIR Res Protoc. 2017 Jul 13;6(7):e136. doi: 10.2196/resprot.7790.
7
Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A systematic review and discussion of latest controversies.
Surgeon. 2021 Oct;19(5):310-320. doi: 10.1016/j.surge.2020.08.016. Epub 2020 Oct 3.
8
Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.
Eur J Surg Oncol. 2021 Nov;47(11):2865-2872. doi: 10.1016/j.ejso.2021.05.046. Epub 2021 Jun 3.
9
Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Dis Colon Rectum. 2017 May;60(5):477-487. doi: 10.1097/DCR.0000000000000774.
10
[Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):230-239. doi: 10.3760/cma.j.cn.441530-20201110-00603.
引用本文的文献
1
Cytoreductive surgery for colorectal peritoneal metastasis in the era modern systemic therapies: a systematic review and meta-analysis of survival outcomes.
Int J Colorectal Dis. 2025 Aug 14;40(1):178. doi: 10.1007/s00384-025-04978-8.
本文引用的文献
1
Cancer statistics, 2022.
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
2
Actual survival after resection of primary colorectal cancer: results from a prospective multicenter study.
World J Surg Oncol. 2021 Apr 5;19(1):96. doi: 10.1186/s12957-021-02207-4.
3
Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis.
Asia Pac J Clin Oncol. 2022 Feb;18(1):7-12. doi: 10.1111/ajco.13552. Epub 2021 Feb 19.
4
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol. 2021 Feb;22(2):256-266. doi: 10.1016/S1470-2045(20)30599-4. Epub 2021 Jan 18.
5
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
Lancet Oncol. 2020 Sep;21(9):1147-1154. doi: 10.1016/S1470-2045(20)30322-3. Epub 2020 Jul 24.
6
Systematic Review of Factors Affecting Quality of Life After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol. 2020 Oct;27(10):3973-3983. doi: 10.1245/s10434-020-08379-9. Epub 2020 Apr 26.
7
Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis.
Eur Radiol. 2020 Jun;30(6):3101-3112. doi: 10.1007/s00330-019-06524-x. Epub 2020 Feb 17.
8
Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis.
Colorectal Dis. 2020 Nov;22(11):1482-1495. doi: 10.1111/codi.15003. Epub 2020 Feb 27.
9
Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
BJS Open. 2019 Sep 18;3(6):812-821. doi: 10.1002/bjs5.50193. eCollection 2019 Dec.
10
Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
BJS Open. 2019 Jun 27;3(5):585-594. doi: 10.1002/bjs5.50179. eCollection 2019 Oct.
Zotero 插件